0000950170-24-020397.txt : 20240226 0000950170-24-020397.hdr.sgml : 20240226 20240226181514 ACCESSION NUMBER: 0000950170-24-020397 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240223 FILED AS OF DATE: 20240226 DATE AS OF CHANGE: 20240226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAUL STEVEN M CENTRAL INDEX KEY: 0001237564 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38958 FILM NUMBER: 24680935 MAIL ADDRESS: STREET 1: C/O ELI LITTY & CO STREET 2: LIIY CORPORATE CENTER DC 1093 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karuna Therapeutics, Inc. CENTRAL INDEX KEY: 0001771917 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 270605902 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-449-2244 MAIL ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 ownership.xml 4 X0508 4 2024-02-23 false 0001771917 Karuna Therapeutics, Inc. KRTX 0001237564 PAUL STEVEN M C/O KARUNA THERAPEUTICS, INC. 99 HIGH STREET, 26TH FLOOR BOSTON MA 02110 true false false false false Common Stock 2024-02-23 4 M false 27510 7.27 A 38106 D Common Stock 2024-02-23 4 M false 4008 99.72 A 42114 D Common Stock 2364 I The Steven M. Paul Revocable Trust Common Stock 83255 I Spouse (Jann E. Paul GRAT III) Common Stock 23230 I Spouse (Jann E. Paul Revocable Trust) Option (right to buy) 7.27 2024-02-23 4 M false 27510 0 D 2028-08-08 Common Stock 27510 757045 D Option (right to buy) 99.72 2024-02-23 4 M false 4008 0 D 2030-02-13 Common Stock 4008 135992 D This option vested as to 1/30th of the shares underlying the option award on each one month anniversary of the vesting commencement date of June 15, 2018, except that 274,594 shares vested upon the closing of our Series B financing in March 2019, and 98,069 shares vested upon the closing of our initial public offering. This option vested as to 25% of the shares on the first anniversary of the vesting commencement date of February 14, 2020, with additional vesting as to 6.25% of the shares underlying the option award on each three month anniversary thereafter. /s/ Mia Kelley, Attorney-in-Fact 2024-02-26